Severe Plaque News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Severe plaque. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Severe Plaque Today - Breaking & Trending Today

Tremfya outperforms IL-17 inhibitors in treatment persistence for plaque psoriasis

Tremfya demonstrated greater treatment persistence than interleukin-17 inhibitors in patients with moderate to severe plaque psoriasis and achieved clinical efficacy in scalp psoriasis, according to data presented here.Tremfya (guselkumab, Janssen Biotech) is the first and only fully human selective interleukin (IL)-23 approved in the United States for adults with moderate to severe plaque ....

United States , Steven Feldman , Bygabrielle Capaldo , Kristen Dowd , American Academy Of Dermatology Annual Meeting , Wake Forest University School Of Medicine , American Academy , Dermatology Annual Meeting , Janssen Biotech , Dermatology Annual , Wake Forest University School , Both Bio Na , Bio Experienced Patients Living With Moderate , Severe Plaque , Published March ,